Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 臨床醫學研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/18346
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor吳明賢(Ming-Shiang Wu),楊偉勛(Wei-Shiung Yang)
dc.contributor.authorPing-Huei Tsengen
dc.contributor.author曾屏輝zh_TW
dc.date.accessioned2021-06-08T01:00:47Z-
dc.date.copyright2015-03-12
dc.date.issued2014
dc.date.submitted2014-12-04
dc.identifier.citationAbbott C.R., Monteiro M., Small C.J., Sajedi A., Smith K.L., Parkinson J.R., Ghatei M.A., Bloom S.R. 2005. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 1044(1):127-131.
Abell T.L., Camilleri M., Donohoe K., Hasler W.L., Lin H.C., Maurer A.H., McCallum R.W., Nowak T., Nusynowitz M.L., Parkman H.P., Shreve P., Szarka L.A., Snape W.J., Jr., Ziessman H.A. 2008. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. J Nucl Med Technol 36(1):44-54.
Adams M.C., Turkington T.G., Wilson J.M., Wong T.Z. 2010. A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol 195(2):310-320.
Ahmed R.L., Schmitz K.H., Anderson K.E., Rosamond W.D., Folsom A.R. 2006. The metabolic syndrome and risk of incident colorectal cancer. Cancer 107(1):28-36.
Anastasios R., Goritsas C., Papamihail C., Trigidou R., Garzonis P., Ferti A. 2002. Helicobacter pylori infection in diabetic patients: prevalence and endoscopic findings. Eur J Intern Med 13(6):376.
Ando K., Takagi K. 2011. Solid gastric emptying mediated by the serotonin (5-HT)3 receptor in mice is a simple marker to predict emesis. J Toxicol Sci 36(1):23-29.
Ando K., Takagi K., Tsubone H. 2012. Enhanced gastric retention of solid resin beads as a marker for emetic potential of agents in rats. J Toxicol Sci 37(3):549-553.
Andres E., Federici L., Imperiale A. 2010. Value of 18 FDG-PET/CT in clinical practice in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome. Eur J Radiol 75(1):122.
Aptel F., Denis P., Rouberol F., Thivolet C. 2008. Screening of diabetic retinopathy: effect of field number and mydriasis on sensitivity and specificity of digital fundus photography. Diabetes Metab 34(3):290-293.
Ardila-Hani A., Arabyan M., Waxman A., Ih G., Berel D., Pimentel M., Conklin J., Soffer E.E. 2013. Severity of dyspeptic symptoms correlates with delayed and early variables of gastric emptying. Dig Dis Sci 58(2):478-487.
Ariizumi K., Koike T., Ohara S., Inomata Y., Abe Y., Iijima K., Imatani A., Oka T., Shimosegawa T. 2008. Incidence of reflux esophagitis and H pylori infection in diabetic patients. World J Gastroenterol 14(20):3212-3217.
Association A.D. 2010. Standards of medical care in diabetes--2010. Diabetes Care 33 Suppl 1:S11-61.
Bakheet S.M., Amin T., Alia A.G., Kuzo R., Powe J. 1999. F-18 FDG uptake in benign esophageal disease. Clin Nucl Med 24(12):995-997.
Barazzoni R., Zanetti M., Nagliati C., Cattin M.R., Ferreira C., Giuricin M., Palmisano S., Edalucci E., Dore F., Guarnieri G., de Manzini N. 2013. Gastric bypass does not normalize obesity-related changes in ghrelin profile and leads to higher acylated ghrelin fraction. Obesity (Silver Spring) 21(4):718-722.
Bhargava P., Reich P., Alavi A., Zhuang H. 2003. Radiation-induced esophagitis on FDG PET imaging. Clin Nucl Med 28(10):849-850.
Boehme M.W., Autschbach F., Ell C., Raeth U. 2007. Prevalence of silent gastric ulcer, erosions or severe acute gastritis in patients with type 2 diabetes mellitus--a cross-sectional study. Hepatogastroenterology 54(74):643-648.
Busing K.A., Schonberg S.O., Brade J., Wasser K. 2013. Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18F-FDG PET/CT. Nucl Med Biol 40(2):206-213.
Bytzer P., Talley N.J., Hammer J., Young L.J., Jones M.P., Horowitz M. 2002. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol 97(3):604-611.
Bytzer P., Talley N.J., Leemon M., Young L.J., Jones M.P., Horowitz M. 2001. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med 161(16):1989-1996.
Camilleri M. 2007. Clinical practice. Diabetic gastroparesis. N Engl J Med 356(8):820-829.
Camilleri M., Iturrino J., Bharucha A.E., Burton D., Shin A., Jeong I.D., Zinsmeister A.R. 2012. Performance characteristics of scintigraphic measurement of gastric emptying of solids in healthy participants. Neurogastroenterol Motil 24(12):1076-e1562.
Cassilly D.W., Wang Y.R., Friedenberg F.K., Nelson D.B., Maurer A.H., Parkman H.P. 2008. Symptoms of gastroparesis: use of the gastroparesis cardinal symptom index in symptomatic patients referred for gastric emptying scintigraphy. Digestion 78(2-3):144-151.
Castell D.O., Vela M. 2001. Combined multichannel intraluminal impedance and pH-metry: an evolving technique to measure type and proximal extent of gastroesophageal reflux. Am J Med 111 Suppl 8A:157S-159S.
Catassi C., Fasano A. 2008. Celiac disease. Curr Opin Gastroenterol 24(6):687-691.
Cellek S., Foxwell N.A., Moncada S. 2003. Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats. Diabetes 52(9):2353-2362.
Chandran M., Phillips S.A., Ciaraldi T., Henry R.R. 2003. Adiponectin: more than just another fat cell hormone? Diabetes Care 26(8):2442-2450.
Chang C., Lu F., Yang Y.C., Wu J.S., Wu T.J., Chen M.S., Chuang L.M., Tai T.Y. 2000. Epidemiologic study of type 2 diabetes in Taiwan. Diabetes Res Clin Pract 50 Suppl 2:S49-59.
Chang C.S., Kao C.H., Wang Y.S., Chen G.H., Wang S.J. 1996. Discrepant pattern of solid and liquid gastric emptying in Chinese patients with type II diabetes mellitus. Nucl Med Commun 17(1):60-65.
Chen C.L., Hsu P.I. 2013. Current advances in the diagnosis and treatment of nonerosive reflux disease. Gastroenterol Res Pract 2013:653989.
Chen C.Y., Fujimiya M., Laviano A., Chang F.Y., Lin H.C., Lee S.D. Modulation of ingestive behavior and gastrointestinal motility by ghrelin in diabetic animals and humans. J Chin Med Assoc 73(5):225-229.
Chen L.S., Liao C.S., Chang S.H., Lai H.C., Chen T.H. 2007. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16). J Med Screen 14(4):191-199.
Chen T.H., Chiu Y.H., Luh D.L., Yen M.F., Wu H.M., Chen L.S., Tung T.H., Huang C.C., Chan C.C., Shiu M.N., Yeh Y.P., Liou H.H., Liao C.S., Lai H.C., Chiang C.P., Peng H.L., Tseng C.D., Yen M.S., Hsu W.C., Chen C.H. 2004. Community-based multiple screening model: design, implementation, and analysis of 42,387 participants. Cancer 100(8):1734-1743.
Chiang T.H., Lee Y.C., Tu C.H., Chiu H.M., Wu M.S. 2011. Performance of the immunochemical fecal occult blood test in predicting lesions in the lower gastrointestinal tract. CMAJ 183(13):1474-1481.
Chiu H.M., Lin J.T., Shun C.T., Liang J.T., Lee Y.C., Huang S.P., Wu M.S. 2007. Association of metabolic syndrome with proximal and synchronous colorectal neoplasm. Clin Gastroenterol Hepatol 5(2):221-229; quiz 141.
Choung R.S., Locke G.R., 3rd, Schleck C.D., Zinsmeister A.R., Melton L.J., 3rd, Talley N.J. 2012. Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population. Am J Gastroenterol 107(1):82-88.
Christian P.E., Datz F.L., Moore J.G. 1991. Confirmation of short solid-food lag phase by continuous monitoring of gastric emptying. J Nucl Med 32(7):1349-1352.
Chung S.J., Kim D., Park M.J., Kim Y.S., Kim J.S., Jung H.C., Song I.S. 2008. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut 57(10):1360-1365.
Corley D.A., Kubo A., Levin T.R., Block G., Habel L., Zhao W., Leighton P., Quesenberry C., Rumore G.J., Buffler P.A. 2007. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 133(1):34-41; quiz 311.
Crowell M.D., Mathis C., Schettler V.A., Yunus T., Lacy B.E. 2005. The effects of tegaserod, a 5-HT receptor agonist, on gastric emptying in a murine model of diabetes mellitus. Neurogastroenterol Motil 17(5):738-743.
De Block C.E., De Leeuw I.H., Pelckmans P.A., Van Gaal L.F. 2006. Current concepts in gastric motility in diabetes mellitus. Curr Diabetes Rev 2(1):113-130.
Debas H.T., Farooq O., Grossman M.I. 1975. Inhibition of gastric emptying is a physiological action of cholecystokinin. Gastroenterology 68(5 Pt 1):1211-1217.
Delgado-Aros S., Camilleri M., Garcia M.A., Burton D., Busciglio I. 2008. High body mass alters colonic sensory-motor function and transit in humans. Am J Physiol Gastrointest Liver Physiol 295(2):G382-388.
Delgado-Aros S., Locke G.R., 3rd, Camilleri M., Talley N.J., Fett S., Zinsmeister A.R., Melton L.J., 3rd. 2004. Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol 99(9):1801-1806.
Drossman D.A. 2006. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 130(5):1377-1390.
Edelstein Z.R., Farrow D.C., Bronner M.P., Rosen S.N., Vaughan T.L. 2007. Central adiposity and risk of Barrett's esophagus. Gastroenterology 133(2):403-411.
Ejskjaer N., Vestergaard E.T., Hellstrom P.M., Gormsen L.C., Madsbad S., Madsen J.L., Jensen T.A., Pezzullo J.C., Christiansen J.S., Shaughnessy L., Kosutic G. 2009. Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis. Aliment Pharmacol Ther 29(11):1179-1187.
El-Salhy M., Mazzawi T., Gundersen D., Hatlebakk J.G., Hausken T. 2013. The role of peptide YY in gastrointestinal diseases and disorders (review). Int J Mol Med 31(2):275-282.
El-Serag H.B., Graham D.Y., Satia J.A., Rabeneck L. 2005. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol 100(6):1243-1250.
Fass R. 2007. Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroenterol 41(2):131-137.
Feldman M., Schiller L.R. 1983. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 98(3):378-384.
Fock K.M., Teo E.K., Ang T.L., Tan J.Y., Law N.M. 2009. The utility of narrow band imaging in improving the endoscopic diagnosis of gastroesophageal reflux disease. Clin Gastroenterol Hepatol 7(1):54-59.
Friedenberg F.K., Xanthopoulos M., Foster G.D., Richter J.E. 2008. The association between gastroesophageal reflux disease and obesity. Am J Gastroenterol 103(8):2111-2122.
Frokjaer J.B., Softeland E., Graversen C., Dimcevski G., Egsgaard L.L., Arendt-Nielsen L., Drewes A.M. 2009. Central processing of gut pain in diabetic patients with gastrointestinal symptoms. Diabetes Care 32(7):1274-1277.
Gaddipati K.V., Simonian H.P., Kresge K.M., Boden G.H., Parkman H.P. 2006. Abnormal ghrelin and pancreatic polypeptide responses in gastroparesis. Dig Dis Sci 51(8):1339-1346.
Gonenne J., Esfandyari T., Camilleri M., Burton D.D., Stephens D.A., Baxter K.L., Zinsmeister A.R., Bharucha A.E. 2006. Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women. Neurogastroenterol Motil 18(10):911-918.
Graham D.Y., Opekun A.R., Willingham F.F., Qureshi W.A. 2005. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol 3(1):55-59.
Gryback P., Hermansson G., Lyrenas E., Beckman K.W., Jacobsson H., Hellstrom P.M. 2000. Nationwide standardisation and evaluation of scintigraphic gastric emptying: reference values and comparisons between subgroups in a multicentre trial. Eur J Nucl Med 27(6):647-655.
Guo J.P., Maurer A.H., Fisher R.S., Parkman H.P. 2001. Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis. Dig Dis Sci 46(1):24-29.
Haag S., Talley N.J., Holtmann G. 2004. Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters. Gut 53(10):1445-1451.
Hamilton VBSR K.S., Riboli E, et al. 2000. Tumours of the colon and rectum. In: Hamilton SR AL, eds. World Health Organization classifications of tumors: pathology and genetics of tumors of the digestive system. Lyon, France: IARC,:103-142.
Hampel H., Abraham N.S., El-Serag H.B. 2005. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 143(3):199-211.
Harberson J., Thomas R.M., Harbison S.P., Parkman H.P. 2010. Gastric neuromuscular pathology in gastroparesis: analysis of full-thickness antral biopsies. Dig Dis Sci 55(2):359-370.
Harsch I.A., Koebnick C., Tasi A.M., Hahn E.G., Konturek P.C. 2009. Ghrelin and obestatin levels in type 2 diabetic patients with and without delayed gastric emptying. Dig Dis Sci 54(10):2161-2166.
Hellmig S., Von Schoning F., Gadow C., Katsoulis S., Hedderich J., Folsch U.R., Stuber E. 2006. Gastric emptying time of fluids and solids in healthy subjects determined by 13C breath tests: influence of age, sex and body mass index. J Gastroenterol Hepatol 21(12):1832-1838.
Herbella F.A., Sweet M.P., Tedesco P., Nipomnick I., Patti M.G. 2007. Gastroesophageal reflux disease and obesity. Pathophysiology and implications for treatment. J Gastrointest Surg 11(3):286-290.
Holub J.L., Silberg D.G., Michaels L.C., Williams J.L., Morris C.D., Eisen G. 2010. Acid-related upper endoscopy findings in patients with diabetes versus non-diabetic patients. Dig Dis Sci 55(10):2853-2859.
Horikawa A., Ishii-Nozawa R., Ohguro M., Takagi S., Ohtuji M., Yamada M., Kuzuya N., Ujihara N., Ujihara M., Takeuchi K. 2009. Prevalence of GORD (gastro-oesophageal reflux disease) in Type 2 diabetes and a comparison of clinical profiles between diabetic patients with and without GORD. Diabet Med 26(3):228-233.
Hsu P.I., Kim N., Goh K.L., Wu D.C. 2013. Diagnosis and management of gastroesophageal reflux disease. Gastroenterol Res Pract 2013:709620.
Huang T.M., Wu V.C., Young G.H., Lin Y.F., Shiao C.C., Wu P.C., Li W.Y., Yu H.Y., Hu F.C., Lin J.W., Chen Y.S., Lin Y.H., Wang S.S., Hsu R.B., Chang F.C., Chou N.K., Chu T.S., Yeh Y.C., Tsai P.R., Huang J.W., Lin S.L., Chen Y.M., Ko W.J., Wu K.D. 2011. Preoperative proteinuria predicts adverse renal outcomes after coronary artery bypass grafting. J Am Soc Nephrol 22(1):156-163.
Imperiale A., Federici L., Lefebvre N., Braun J.J., Pfumio F., Kessler R., Hansmann Y., Andres E., Constantinesco A. 2010. F-18 FDG PET/CT as a valuable imaging tool for assessing treatment efficacy in inflammatory and infectious diseases. Clin Nucl Med 35(2):86-90.
Isomoto H., Nishi Y., Kanazawa Y., Shikuwa S., Mizuta Y., Inoue K., Kohno S. 2007. Immune and Inflammatory Responses in GERD and Lansoprazole. J Clin Biochem Nutr 41(2):84-91.
James A.N., Ryan J.P., Crowell M.D., Parkman H.P. 2004. Regional gastric contractility alterations in a diabetic gastroparesis mouse model: effects of cholinergic and serotoninergic stimulation. Am J Physiol Gastrointest Liver Physiol 287(3):G612-619.
Jin H.Y., Kang Y.M., Kim C.Y., Kim S.H., Liu W.J., Piao M.H., Park J.H., Baek H.S., Park T.S. 2009. Morphological comparison of small nerve fibres in gastric mucosa in non-diabetic and Type 2 diabetic subjects. Diabet Med 26(9):943-946.
Jungling B., Schleiffer T., Buttmann A., Kraatz K., Kress S., Vogt M., Windeler J., Riemann J.F. 2001. Postprandial blood glucose latency after oatmeal is a valid screening test for diabetic gastropathy in type 1 diabetes, but not in type 2 diabetes. Dig Dis Sci 46(4):713-722.
Kamimura K., Fujita S., Nishii R., Wakamatsu H., Nagamachi S., Yano T., Ogita M., Umemura Y., Fujimoto T., Nakajo M. 2007. An analysis of the physiological FDG uptake in the stomach with the water gastric distention method. Eur J Nucl Med Mol Imaging 34(11):1815-1818.
Kao C.H., Lai T.L., Wang S.J., Chen G.H., Yeh S.H. 1994. Influence of age on gastric emptying in healthy Chinese. Clin Nucl Med 19(5):401-404.
Karmiris K., Koutroubakis I.E., Xidakis C., Polychronaki M., Voudouri T., Kouroumalis E.A. 2006. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis 12(2):100-105.
Keku T.O., Lund P.K., Galanko J., Simmons J.G., Woosley J.T., Sandler R.S. 2005. Insulin resistance, apoptosis, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 14(9):2076-2081.
Kim B.J., Kim Y.H., Sinn D.H., Kang K.J., Kim J.Y., Chang D.K., Son H.J., Rhee P.L., Kim J.J., Rhee J.C. 2010. Clinical usefulness of glycosylated hemoglobin as a predictor of adenomatous polyps in the colorectum of middle-aged males. Cancer Causes Control 21(6):939-944.
Kinekawa F., Kubo F., Matsuda K., Fujita Y., Tomita T., Uchida Y., Nishioka M. 2001. Relationship between esophageal dysfunction and neuropathy in diabetic patients. Am J Gastroenterol 96(7):2026-2032.
Klingensmith W.C., 3rd, Lawrence S.P. 2008. The gastric emptying study: protocol design considerations. J Nucl Med Technol 36(4):195-199.
Klingensmith W.C., 3rd, Rhea K.L., Wainwright E.A., Hopper O.W. 2010. The gastric emptying study with oatmeal: reference range and reproducibility as a function of age and sex. J Nucl Med Technol 38(4):186-190.
Knight L.C. 2012. Update on gastrointestinal radiopharmaceuticals and dosimetry estimates. Semin Nucl Med 42(2):138-144.
Ko G.T., Chan W.B., Chan J.C., Tsang L.W., Cockram C.S. 1999. Gastrointestinal symptoms in Chinese patients with Type 2 diabetes mellitus. Diabet Med 16(8):670-674.
Kukulka M., Eisenberg C., Nudurupati S. 2011. Comparator pH study to evaluate the single-dose pharmacodynamics of dual delayed-release dexlansoprazole 60 mg and delayed-release esomeprazole 40 mg. Clin Exp Gastroenterol 4:213-220.
Lam E.K., Batty G.D., Huxley R.R., Martiniuk A.L., Barzi F., Lam T.H., Lawes C.M., Giles G.G., Welborn T., Ueshima H., Tamakoshi A., Woo J., Kim H.C., Fang X., Czernichow S., Woodward M. 2010. Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region. Ann Oncol 22(3):730-738.
Lankarani K.B., Moghadami M., Masoumpoor M., Geramizadeh B., Omrani G.R. 2004. Serum leptin level in patients with functional dyspepsia. Dig Liver Dis 36(11):717-721.
Larsson S.C., Giovannucci E., Wolk A. 2005a. Diabetes and colorectal cancer incidence in the cohort of Swedish men. Diabetes Care 28(7):1805-1807.
Larsson S.C., Orsini N., Wolk A. 2005b. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97(22):1679-1687.
Lee Y.C., Lin J.T., Chiu H.M., Liao W.C., Chen C.C., Tu C.H., Tai C.M., Chiang T.H., Chiu Y.H., Wu M.S., Wang H.P. 2007. Intraobserver and interobserver consistency for grading esophagitis with narrow-band imaging. Gastrointest Endosc 66(2):230-236.
Lee Y.C., Yen A.M., Tai J.J., Chang S.H., Lin J.T., Chiu H.M., Wang H.P., Wu M.S., Chen T.H. 2009. The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease. Gut 58(2):174-181.
Li Q., Kong L., Zhang S., Zhong Z., Liu X., Wang J., Kang J. 2010. A novel external esophageal perfusion model for reflux-associated respiratory symptoms. Pathobiology 77(3):163-168.
Li Y., Woodall C., Wo J.M., Zheng H., Ng C.K., Ray M.B., Martin R.C. 2008. The use of dynamic positron emission tomography imaging for evaluating the carcinogenic progression of intestinal metaplasia to esophageal adenocarcinoma. Cancer Invest 26(3):278-285.
Lien H.C., Chang C.S., Chen G.H., Kao C.H., Tsai S.C., Wang S.J., Fu J.J. 1999. Gastric emptying rate assessment based on the proportion of intra-abdominal radioactivity in the stomach. J Nucl Med 40(7):1106-1110.
Lien H.C., Wang C.C., Liang W.M., Sung F.C., Hsu J.Y., Yeh H.Z., Chong K., Chang C.S. 2013. Composite pH predicts esomeprazole response in laryngopharyngeal reflux without typical reflux syndrome. Laryngoscope 123(6):1483-1489.
Lin H.C., Van Citters G.W., Zhao X.T., Waxman A. 1999. Fat intolerance depends on rapid gastric emptying. Dig Dis Sci 44(2):330-335.
Lin Y.Y., Tseng T.J., Hsieh Y.L., Luo K.R., Lin W.M., Chiang H., Hsieh S.T. 2008. Depletion of peptidergic innervation in the gastric mucosa of streptozotocin-induced diabetic rats. Exp Neurol 213(2):388-396.
Lu C.L., Chang S.S., Wang S.S., Chang F.Y., Lee S.D. 2004. Silent peptic ulcer disease: frequency, factors leading to 'silence,' and implications regarding the pathogenesis of visceral symptoms. Gastrointest Endosc 60(1):34-38.
Lundell L.R., Dent J., Bennett J.R., Blum A.L., Armstrong D., Galmiche J.P., Johnson F., Hongo M., Richter J.E., Spechler S.J., Tytgat G.N., Wallin L. 1999. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 45(2):172-180.
Maier C., Riedl M., Vila G., Nowotny P., Wolzt M., Clodi M., Ludvik B., Luger A. 2008. Cholinergic regulation of ghrelin and peptide YY release may be impaired in obesity. Diabetes 57(9):2332-2340.
Mainie I., Tutuian R., Shay S., Vela M., Zhang X., Sifrim D., Castell D.O. 2006. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 55(10):1398-1402.
Maleki D., Locke G.R., 3rd, Camilleri M., Zinsmeister A.R., Yawn B.P., Leibson C., Melton L.J., 3rd. 2000. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med 160(18):2808-2816.
Maloy T., Herrera M., Zimmer M., Spies S. June 6, 2011. p. 2334. Optimal radiolabelling methods for Tc99m sulfur colloid oatmeal products for gastric emptying. Society of Nuclear Medicine 58th Annual Meeting.
Mashimo H., Kjellin A., Goyal R.K. 2000. Gastric stasis in neuronal nitric oxide synthase-deficient knockout mice. Gastroenterology 119(3):766-773.
Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412-419.
Maurer A.H. 2012. Advancing gastric emptying studies: standardization and new parameters to assess gastric motility and function. Semin Nucl Med 42(2):101-112.
McCallum R.W., Berkowitz D.M., Lerner E. 1981. Gastric emptying in patients with gastroesophageal reflux. Gastroenterology 80(2):285-291.
Mehta N., Veliath S., Thombre D.P. 2002. Effect of experimental diabetes and vagotomy on gastric emptying in rats. Indian J Physiol Pharmacol 46(4):441-448.
Mellem H., Stave R., Myren J., Osnes M., Hanssen L.E., Mosvold J., Hebnes K. 1985. Symptoms in patients with peptic ulcer and hematemesis and/or melena related to the use of non-steroid anti-inflammatory drugs. Scand J Gastroenterol 20(10):1246-1248.
Metser U., Even-Sapir E. 2007. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT. Semin Nucl Med 37(3):206-222.
Mine S., Iida T., Tabata T., Okada Y., Tanaka Y. 2008. Increased esophageal mucosal/submucosal blood flow in patients with gastroesophageal reflux disease: normalization by treatment with a proton pump inhibitor. J Gastroenterol Hepatol 23(2):303-309.
Mittra E., Rubin C., Gruber B., Qin Y.X. 2008. Evaluation of trabecular mechanical and microstructural properties in human calcaneal bone of advanced age using mechanical testing, microCT, and DXA. J Biomech 41(2):368-375.
Murray C.D., Martin N.M., Patterson M., Taylor S.A., Ghatei M.A., Kamm M.A., Johnston C., Bloom S.R., Emmanuel A.V. 2005. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 54(12):1693-1698.
Nam S.Y., Choi I.J., Ryu K.H., Park B.J., Kim H.B., Nam B.H. 2010. Abdominal visceral adipose tissue volume is associated with increased risk of erosive esophagitis in men and women. Gastroenterology 139(6):1902-1911 e1902.
Ott K., Weber W., Siewert J.R. 2006. The importance of PET in the diagnosis and response evaluation of esophageal cancer. Dis Esophagus 19(6):433-442.
Parkman H.P., Hasler W.L., Fisher R.S. 2004. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 127(5):1592-1622.
Parkman H.P., Schwartz S.S. 1987. Esophagitis and gastroduodenal disorders associated with diabetic gastroparesis. Arch Intern Med 147(8):1477-1480.
Peles S., Medda B.K., Zhang Z., Banerjee B., Lehmann A., Shaker R., Sengupta J.N. 2009. Differential effects of transient receptor vanilloid one (TRPV1) antagonists in acid-induced excitation of esophageal vagal afferent fibers of rats. Neuroscience 161(2):515-525.
Peura D.A., Metz D.C., Dabholkar A.H., Paris M.M., Yu P., Atkinson S.N. 2009. Safety profile of dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed release formulation: global clinical trial experience. Aliment Pharmacol Ther 30(10):1010-1021.
Peura D.A., Pilmer B., Hunt B., Mody R., Perez M.C. 2013. Distinguishing the impact of dexlansoprazole on heartburn vs. regurgitation in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 38(10):1303-1311.
Poitras P., Picard M., Dery R., Giguere A., Picard D., Morais J., Plourde V., Boivin M. 1997. Evaluation of gastric emptying function in clinical practice. Dig Dis Sci 42(11):2183-2189.
Quatrini M., Boarino V., Ghidoni A., Baldassarri A.R., Bianchi P.A., Bardella M.T. 2001. Helicobacter pylori prevalence in patients with diabetes and its relationship to dyspeptic symptoms. J Clin Gastroenterol 32(3):215-217.
Rastogi A., Puli S., El-Serag H.B., Bansal A., Wani S., Sharma P. 2008. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc 67(3):394-398.
Rayner C.K., Samsom M., Jones K.L., Horowitz M. 2001. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 24(2):371-381.
Revicki D.A., Rentz A.M., Dubois D., Kahrilas P., Stanghellini V., Talley N.J., Tack J. 2004. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res 13(4):833-844.
Riley J., Eisenberg E., Muller-Schwefe G., Drewes A.M., Arendt-Nielsen L. 2008. Oxycodone: a review of its use in the management of pain. Curr Med Res Opin 24(1):175-192.
Roedl J.B., Colen R.R., King K., Fischman A.J., Mueller P.R., Blake M.A. 2008. Visual PET/CT scoring for nonspecific 18F-FDG uptake in the differentiation of early malignant and benign esophageal lesions. AJR Am J Roentgenol 191(2):515-521.
Sachdeva P., Malhotra N., Pathikonda M., Khayyam U., Fisher R.S., Maurer A.H., Parkman H.P. 2011. Gastric emptying of solids and liquids for evaluation for gastroparesis. Dig Dis Sci 56(4):1138-1146.
Salaun P.Y., Grewal R.K., Dodamane I., Yeung H.W., Larson S.M., Strauss H.W. 2005. An analysis of the 18F-FDG uptake pattern in the stomach. J Nucl Med 46(1):48-51.
Sarnelli G., Caenepeel P., Geypens B., Janssens J., Tack J. 2003. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 98(4):783-788.
Sato T., Ida T., Nakamura Y., Shiimura Y., Kangawa K., Kojima M. 2014. Physiological roles of ghrelin on obesity. Obes Res Clin Pract 8(5):e405-e413.
Saydah S.H., Platz E.A., Rifai N., Pollak M.N., Brancati F.L., Helzlsouer K.J. 2003. Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 12(5):412-418.
Schaffler A., Scholmerich J. 2009. The role of adiponectin in inflammatory gastrointestinal diseases. Gut 58(3):317-322.
Schimke K., Chubb S.A., Davis W.A., Phillips P., Davis T.M. 2009. Antiplatelet therapy, Helicobacter pylori infection and complicated peptic ulcer disease in diabetes: the Fremantle Diabetes Study. Diabet Med 26(1):70-75.
Selim M.M., Wendelschafer-Crabb G., Redmon J.B., Khoruts A., Hodges J.S., Koch K., Walk D., Kennedy W.R. 2010. Gastric mucosal nerve density: a biomarker for diabetic autonomic neuropathy? Neurology 75(11):973-981.
Shao Y., Yuan G., Feng Y., Zhang J., Guo X. 2014. Early liraglutide treatment is better in glucose control, beta-cell function improvement and mass preservation in db/db mice. Peptides 52:134-142.
Sharma P., Wani S., Bansal A., Hall S., Puli S., Mathur S., Rastogi A. 2007. A feasibility trial of narrow band imaging endoscopy in patients with gastroesophageal reflux disease. Gastroenterology 133(2):454-464; quiz 674.
Shaw M. 2004. Diagnostic utility of reflux disease symptoms. Gut 53 Suppl 4:iv25-27.
Sheu B.S., Chang W.L., Cheng H.C., Kao A.W., Lu C.C. 2008. Body mass index can determine the healing of reflux esophagitis with Los Angeles Grades C and D by esomeprazole. Am J Gastroenterol 103(9):2209-2214.
Sheu B.S., Cheng H.C., Chang W.L., Chen W.Y., Kao A.W. 2007. The impact of body mass index on the application of on-demand therapy for Los Angeles grades A and B reflux esophagitis. Am J Gastroenterol 102(11):2387-2394.
Shih H.C., Chou P., Chen S.J., Liu J.H., Lee F.L., Liu C.M., Tung T.H. 2007. A community-based study of the willingness to pay associated with screening for diabetic retinopathy among type 2 diabetes in Kinmen, Taiwan. J Epidemiol 17(6):186-193.
Shindo T., Futagami S., Hiratsuka T., Horie A., Hamamoto T., Ueki N., Kusunoki M., Miyake K., Gudis K., Tsukui T., Iwakiri K., Sakamoto C. 2009. Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and non-erosive reflux disease. Digestion 79(2):65-72.
Siddique R., Ricci J.A., Stewart W.F., Sloan S., Farup C.E. 2002. Quality of life in a US national sample of adults with diabetes and motility-related upper gastrointestinal symptoms. Dig Dis Sci 47(4):683-689.
Spiekerkoetter U., Seissler J., Wendel U. 2002. General screening for celiac disease is advisable in children with type 1 diabetes. Horm Metab Res 34(4):192-195.
Spier B.J., Perlman S.B., Jaskowiak C.J., Reichelderfer M. 2010. PET/CT in the evaluation of inflammatory bowel disease: studies in patients before and after treatment. Mol Imaging Biol 12(1):85-88.
Stanghellini V., Tosetti C., Paternico A., Barbara G., Morselli-Labate A.M., Monetti N., Marengo M., Corinaldesi R. 1996. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 110(4):1036-1042.
Tack J., Talley N.J., Camilleri M., Holtmann G., Hu P., Malagelada J.R., Stanghellini V. 2006. Functional gastroduodenal disorders. Gastroenterology 130(5):1466-1479.
Talley N.J., Stanghellini V., Heading R.C., Koch K.L., Malagelada J.R., Tytgat G.N. 1999. Functional gastroduodenal disorders. Gut 45 Suppl 2:II37-42.
Talley N.J., Verlinden M., Jones M. 2001a. Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia? Am J Gastroenterol 96(5):1422-1428.
Talley N.J., Young L., Bytzer P., Hammer J., Leemon M., Jones M., Horowitz M. 2001b. Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol 96(1):71-76.
Thomsen R.W., Riis A., Christensen S., Norgaard M., Sorensen H.T. 2006. Diabetes and 30-day mortality from peptic ulcer bleeding and perforation: a Danish population-based cohort study. Diabetes Care 29(4):805-810.
Tomita T., Okugawa T., Yamasaki T., Kondo T., Toyoshima F., Sakurai J., Oshima T., Fukui H., Daimon T., Watari J., Kashiwagi T., Matsumoto T., Miwa H. 2013. Use of scintigraphy to evaluate gastric accommodation and emptying: Comparison with barostat. J Gastroenterol Hepatol 28(1):106-111.
Touga
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/18346-
dc.description.abstract背景及目的
在台灣,包括糖尿病及肥胖在內的代謝症候群的盛行率逐年上升。許多糖尿病患者常會出現胃腸併發症,包括胃食道逆流、胃輕癱、腹瀉、便祕等,常會影響患者之生活品質及血糖控制。糖尿病患者之自律神經病變,如何造成胃腸道運動功能失調及胃腸道症狀,目前仍不清楚。此外,流行病學研究發現,胃食道逆流症進展之自然史及大腸息肉的發生與代謝症候群有密切的關係。然而,其間詳細之病理生理機轉目前亦不完全明瞭。氟-18氟化葡萄糖,可蓄積於發炎部位,具有與發炎細胞代謝活性成正相關的特性,因此,氟-18氟化葡萄糖正子斷層掃描不但可以評估解剖結構上的異常,也可以同時評估局部葡萄糖代謝或是發炎的程度,似乎可以作為評估食道發炎與肥胖之間複雜關係之創新工具。因此,本研究結合臨床與基礎動物實驗,建立跨科目的研究模式,探討以糖尿病及肥胖為主之代謝因子對胃腸道臨床表現之影響,此結果將有助於釐清代謝危險因子與胃腸疾病的發生或病程進展間的關係,找出這些可能的致病途徑及中間因子並予以移除或治療,以避免嚴重之胃腸道併發症的發生。
研究對象與方法
本研究第一部分,利用台大醫院建立之完整健康檢查資料庫,藉由與一般非糖尿病族群之對照比較,分析糖尿病患者各種主觀胃腸道症狀及客觀之上下消化道內視鏡病灶之盛行率及獨特臨床表現,並進一步探討其與血糖控制狀況及各種糖尿病併發症的交互關係。本研究第二部分進一步延伸,利用健康檢查資料庫中同時接受氟-18氟化葡萄糖的全身正子斷層掃描及上消化道內視鏡檢查的個案,同步定量食道發炎程度、皮下及內臟脂肪量,據以探討肥胖、發炎與胃食道逆流症主觀症狀(問卷計分高低)及客觀食道發炎糜爛情形(洛杉磯分類)之關聯。本研究之第三部分則是前瞻性招募60名志願之健康受試者,建立起以即沖即食之大燕麥片為試驗餐包及流程簡化的胃排空時間造影術,提供運用在華人所需的正常標準值,包括排空一半所需時間,第0.5、1、2、3小時胃殘存同位素活性比例。此外,我們將此正常值應用於有上腹不適症狀,如噁心、嘔吐、打呃或餐後飽脹等之糖尿病及功能性消化不良患者,藉以評估胃排空速率。最後,我們利用第二型糖尿病的動物模式C57BLKS/J db/db小鼠,建立以樹脂珠子為基礎之固體胃排空測定方法,並配合胰島素或藥物之血糖控制,探討血糖控制與胃排空功能之關聯。
結果
本研究第一部分發現,糖尿病患者各種主觀胃腸道症狀相較於一般非糖尿病族群顯著較低 (30.3% vs. 35.4%, P = 0.006);相反地,各種客觀之上下消化道內視鏡病灶盛行率則顯著較高,包括糜爛性食道炎 (34.3% vs. 28.6%, P = 0.002), 巴瑞特氏食道 (0.6% vs. 0.1%, P = 0.001), 消化性潰瘍 (14.8% vs. 8.5%, P < 0.001), 胃息肉 (1.8% vs. 0.7%, P = 0.003) 以及大腸息肉 (26.6% vs. 16.5%, P < 0.001)。較高的血中糖化血紅素濃度也與較少的胃腸道症狀及較多的胃腸道內視鏡異常有關。有糖尿病併發症的患者也有較高比例患有大腸息肉(39.2% vs. 24.5%, P = 0.002)。
本研究之第二部分發現,糜爛性食道炎個案的氟-18氟化葡萄糖最大標準攝入值(SUVmax)在食道上、中、下各段均顯著較高,胃或十二指腸則沒有顯著差異。巴瑞特氏食道的個案在食道中段(3.18 ± 1.06)和食道胃交界(3.95 ± 1.35)有最高的SUVmax。胃食道逆流症狀方面,胸口灼熱分項計分和逆流症狀問卷總計分與中間食道較高的SUVmax呈現正相關。利用多元逐步回歸分析,總膽固醇濃度(P = 0.003)和皮下脂肪組織(P < 0.001)與上食道括約肌較高之SUVmax值有關,而飲酒(P = 0.03)和身體質量指數(P < 0.001)與食道中段較高SUVmax相關,年齡(P = 0.027)及腰圍(P < 0.001)則與食道胃交界處較高的SUVmax相關。
本研究之第三部分發現,有症狀的患者之3小時胃殘留值顯著大於健康志願者的(3.7 ± 5.8 % vs. 2.0 ± 2.4%,P = 0.04)。有症狀的患者中,分別有4位(13%)和3位(10%)的糖尿病患者被診斷為延遲和快速胃排空;而功能性消化不良患者中有4位(13%)為延遲胃排空。此外,胃排空參數與多項胃輕癱症狀呈現正相關,此相關性在糖尿病患者中比在功能性消化不良患者中為強。年齡、性別和停經前後並無顯著影響胃排空結果。雖然身體質量指數並不影響胃排空參數,腰圍與1小時的胃殘留比例則是呈現負相關(r =-0.329,P = 0.013)。
動物研究方面,八週齡之db/db小鼠(糖尿病組),相較於同齡之db/m小鼠(血糖正常對照組),體重顯著較重(36.5 ± 3.2 vs. 21.5 ± 1.5 公克,P < 0.001),空腹血糖顯著較高(388 ± 49 vs. 131 ± 14 mg/dL,P < 0.001),胃排空速率則是顯著較快(80 ± 18 vs.48 ± 16 %,P = 0.018)。十二週齡及十六週齡之db/db小鼠胃排空速率減慢,接受胰島素及類昇醣激素胜肽類似物liraglutide之治療則觀察到胃排空速率增快。
結論
本研究發現,糖尿病及偏高的糖化血紅素值與較低的胃腸道症狀盛行率及較高的內視鏡病灶盛行率相關,這可能造成糖尿病病患之胃腸道問題被低估或忽視,進而引發更嚴重之併發症。正子斷層掃描顯示之食道發炎程度與胃食道逆流症之內視鏡表現及症狀學有關,本研究進一步證實,肥胖指標,包括身體質量指數,腰圍,內臟和皮下脂肪量與糜爛性食道炎的產生及食道發炎程度的增加有關。此外,本研究建立以即沖即食大燕麥片為試驗餐包及簡化流程之胃排空時間造影術及華人之正常標準值,將有助於未來對胃排空障礙疾病的診斷與評估。最後,本研究建立第二型糖尿病db/db小鼠之固體胃排空測定方法,此動物模式方便可行,未來將可廣泛應用於探討代謝因子與自律神經病變之因果關聯性及相關機制。
zh_TW
dc.description.abstractBackground and objective
Metabolic syndrome, especially diabetes mellitus (DM) and obesity, has been associated a myriad of gastrointestinal (GI) complications, including gastroesophageal reflux disease (GERD), gastroparesis, constipation and diarrhea. The pathogenesis of GI complications in patients with metabolic derangement is complex and multi-factorial. Epidemiological studies have shown a close relationship between obesity and GERD-related complications. 18F-Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) assesses not only anatomical structures, but also the degree of local glucose metabolism and provides us a unique opportunity to explore the complex relationship of GERD, esophageal inflammation and obesity. With the integrated approaches with both clinical and animal studies, we aim to investigate the clinical implication and underlying pathophysiology of metabolic factors of the various GI diseases.
Materials and methods
First, we analyzed the prevalence and severity of GI symptoms and endoscopic findings in diabetic subjects from a general population undergoing upper endoscopy/colonoscopy as part of a medical examination at the National Taiwan University Hospital. Second, we studied 458 subjects who underwent both an upper gastrointestinal endoscopy and FDG PET/CT during health check-ups. GERD symptoms were evaluated with Reflux Disease Questionnaire. Inflammatory activity, represented by standardized uptake values (SUVmax) of FDG at pre-determined locations of esophagus, stomach and duodenum, were compared. Third, to establish normal oatmeal-based gastric emptying scintigraphy reference values and test its correlation with gastroparesis symptoms in the Chinese population, we prospectively enrolled 60 healthy volunteers and 60 symptomatic patients (30 functional dyspepsia and 30 diabetes patients with gastroparesis symptoms). All participants were evaluated using the Gastroparesis Cardinal Symptom Index. Finally, we established the solid gastric emptying measurement with “beads method” in murine models of type 2 DM, C57BLKS/J db/db mice. We investigated the effect of glycemic control with insulin and GLP-1 analogue treatment on the gastric emptying of db/db mice..
Results
In the first part, among the 7770 study subjects, 722 (9.3%) were diagnosed with DM. The overall prevalence of GI symptoms was lower in DM subjects (30.3% vs. 35.4%, P = 0.006). In contrast, the prevalence of erosive esophagitis, Barrett’s esophagus, peptic ulcer disease, gastric neoplasms, and colonic neoplasms were higher in diabetic subjects. Higher HbA1c levels were associated with a decrease of GI symptoms and an increase of endoscopic abnormalities.
Second, subjects with erosive esophagitis on endoscopy had significantly higher SUVmax at esophagus, but not in stomach or duodenum. The severity of erosive esophagitis correlated with SUVmax and subjects with Barrett’s esophagus had the highest SUVmax at middle esophagus and esophagogastric junction. Heartburn positively correlated with higher SUVmax at middle esophagus. Using multivariate regression analyses, age, total cholesterol level, alcohol drinking, subcutaneous adipose tissue, BMI and waist circumference were independently associated with higher SUVmax at respective esophageal locations.
Third, all participants finished the oatmeal-based test meal and tolerated the scintigraphy procedure well. All gastric emptying parameters were not significantly affected by age or gender. Waist circumference inversely correlated with gastric retention at 1 h. There were 4 (13.3%) diabetic patients found to have delayed emptying and 3 patients (10%) found to have rapid emptying, respectively. Gastric emptying parameters correlated best with vomiting severity in diabetic patients.
For the animal studies, body weight (36.5 ± 3.2 vs. 21.5 ± 1.5 gm,P < 0.001) and fasting blood glucose (388 ± 49 vs. 131 ± 14 mg/dL,P < 0.001) were significantly higher in db/db mice than in db/m mice of the same age of 8 weeks. Solid gastric emptying measured with beads method was also faster in the db/db group (80 ± 18 vs. 48 ± 16 %,P = 0.018). Gastric emptying was slower in db/db mice of 12 and 16 weeks of age, while treatment with insulin or liraglutide accelerated the gastric emptying.
Conclusion
In conclusion, the present study shows that DM and higher levels of HbA1c are associated with lower prevalence of GI symptoms but higher prevalence of endoscopic abnormalities. Esophageal inflammation demonstrated by FDG PET/CT correlates with endoscopic findings and symptomatology of GERD. Obesity markers, both visceral and general, are independent determinants of esophageal inflammation. Furthermore, we established normal values of a simplified oatmeal-based gastric emptying scintigraphy and observe good correlation with various gastroparesis symptoms in the Chinese population. Finally, our animal model of measuring solid gastric emptying in db/db mice may be applied to further studies and may help to clarify the temporal relationship between metabolic factors and autonomic neuropathy in GI motility disorders.
en
dc.description.provenanceMade available in DSpace on 2021-06-08T01:00:47Z (GMT). No. of bitstreams: 1
ntu-103-D98421015-1.pdf: 2400776 bytes, checksum: a6acf54ca1304c95ce3e4ee25f9f832b (MD5)
Previous issue date: 2014
en
dc.description.tableofcontents一、誌謝 v
二、中文摘要 vi
三、英文摘要 ix
四、博士論文內容
1. 緒論
(1) 糖尿病與胃腸道併發症 2
(2) 糖尿病與胃排空功能障礙 5
(3) 代謝因子與胃食道逆流症 7
(4) 代謝因子與消化道腫瘤/癌症 11
(5) 胃腸道賀爾蒙與胃腸道疾病 13
(6) 研究代謝因子與胃腸蠕動之動物模式 15
(7) 研究的假說與特定目的 18
2. 研究方法與材料
(1) 第一部分: 胃腸道併發症在糖尿病華人之盛行率及臨床特徵21
(2) 第二部分: 運用正子斷層掃描探討肥胖、發炎與胃食道逆流症25
(3) 第三部分: 糖尿病與胃排空功能障礙28
(4) 第四部分: 建立第二型糖尿病之db/db小鼠與胃排空檢查模式31
(5) 統計分析 33
3. 結果
(1) 第一部分: 胃腸道併發症在糖尿病華人之盛行率及臨床特徵 35
(2) 第二部分: 運用正子斷層掃描探討肥胖、發炎與胃食道逆流症39
(3) 第三部分: 糖尿病與胃排空功能障礙 41
(4) 第四部分: 建立第二型糖尿病之db/db小鼠與胃排空檢查模式 43
4. 討論 44
5. 展望 64
6. 論文英文簡述 74
7. 參考文獻 99
8. 圖 114
9. 表 130
五、附錄 148
1. 本論文之相關論文發表 148
2. 博士班修業期間之相關論文發表 149
dc.language.isozh-TW
dc.title代謝因子於胃腸道疾病之臨床意義及病態生理學研究zh_TW
dc.titleClinical Implication and Pathophysiology of Metabolic Factors in Gastrointestinal Diseaseen
dc.typeThesis
dc.date.schoolyear103-1
dc.description.degree博士
dc.contributor.oralexamcommittee王秀伯(Hsiu-Po Wang),謝松蒼(Sung-Tsang Hsieh),盧俊良(Ching-Liang Lu),邱正堂(Cheng-Tang Chiu)
dc.subject.keyword代謝症候群,糖尿病,胃食道逆流症,氟化葡萄糖,正子掃描電腦斷層,自律神經病變,胃輕癱,功能性消化不良,胃排空時間造影術,db/db小鼠,zh_TW
dc.subject.keywordmetabolic syndrome,diabetes mellitus,gastroesophageal reflux disease,gastroparesis,functional dyspepsia,autonomic neuropathy,FDG PET/CT,gastric emptying scintigraphy,db/db mice,en
dc.relation.page151
dc.rights.note未授權
dc.date.accepted2014-12-04
dc.contributor.author-college醫學院zh_TW
dc.contributor.author-dept臨床醫學研究所zh_TW
顯示於系所單位:臨床醫學研究所

文件中的檔案:
檔案 大小格式 
ntu-103-1.pdf
  未授權公開取用
2.34 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved